Evidence summary
Nutrients 14(17):3474 Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J (2022) Microbiota in health and diseases
We are not a medical provider
Research peptides sit in a distinct category from licensed medicines under UK frameworks
Unlike the DAC version, CJC1295 without DAC does not bind to albumin, resulting in a shorter halflife and more frequent administration schedule
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) New England Journal of Medicine In 3,297 patients with T2D, semaglutide reduced major adverse cardiovascular events by 26% versus placebo over 2.1 years (HR 0.74), driven by 39% stroke reduction and 26% nonfatal MI reduction